Diabetes and Metabolism

Aims & Scope

Diabetes & Metabolism, publishes high-quality original research papers by internationally leading teams, forming a close link between hospital and research units.

Official publication of the French Society for the Study of Diabetes (SFD), the journal features original articles, short reports and comprehensive reviews.

The latter are updates written by internationally recognized specialists carefully edited in order to help clinicians and researchers keep informed about the latest developments in the field of diabetes.

All articles are peer-reviewed and the journal is indexed in all major databases with its impact factor constantly progressing.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.7
2024	4.60

Journal Rank

Year	Value
2024	2038

Journal Citation Indicator

Year	Value
2024	926

SJR (SCImago Journal Rank)

Year	Value
2024	1.648

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	110

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Adipokines: The missing link between insulin resistance and obesity

  Citation: 543

  Authors: B., B., S., J.-P.

• Inflammation and type 2 diabetes

  Citation: 398

  Authors: M.C., M.L.

• Role of the liver in the control of carbohydrate and lipid homeostasis

  Citation: 351

  Authors: C, R, J

• Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

  Citation: 347

  Authors: F, Ph, M

• Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

  Citation: 307

  Authors: M.S., A.-M., J.K., A., H.C., S., B., M.

• Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics

  Citation: 307

  Authors: K., D., D., S., K., H., C., I.M.

• Adipose tissue and adipokines: for better or worse

  Citation: 267

  Authors: M

• Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease

  Citation: 262

  Authors: F., A.J.

• European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary

  Citation: 245

  Authors: Alan J., Giuseppe, Marta, Isabelle, Roger, Leocadio

• The role of the lipogenic pathway in the development of hepatic steatosis

  Citation: 229

  Authors: C., J.

---